Biomaterials

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Biomaterials is a journal published by Elsevier BV in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,740 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
1878-5905 · 0142-9612
Country
United Kingdom
Access
Not open access / not declared
Declared publication charge
4,740 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1980-01-01
  • PUBMED · 2008-06-03
Indexing
MEDLINE · PUBMED
APC
4,740 USD
Declared review time (DOAJ)
—
Actual review time (measured)
129 days received→accepted — computed from PubMed (n=97)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

22746

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

491

i10-index

18713

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2027
Level 2 — top tier (~20% of the field's channels)
Open references deposited at Crossref
95%
ORCID iDs in current deposits
95%
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
8100316
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Bone Tissue Engineering Materials
  • Bone Tissue Engineering Materials
  • Electrospun Nanofibers in Biomedical Applications
  • Electrospun Nanofibers in Biomedical Applications
  • Nanoplatforms for cancer theranostics
  • Nanoplatforms for cancer theranostics
  • RNA Interference and Gene Delivery
  • RNA Interference and Gene Delivery
Show all subjects (50)
  • 3D Printing in Biomedical Research
  • 3D Printing in Biomedical Research
  • Nanoparticle-Based Drug Delivery
  • Nanoparticle-Based Drug Delivery
  • Tissue Engineering and Regenerative Medicine
  • Tissue Engineering and Regenerative Medicine
  • Orthopaedic implants and arthroplasty
  • Orthopaedic implants and arthroplasty
  • Polymer Surface Interaction Studies
  • Polymer Surface Interaction Studies
  • Advanced biosensing and bioanalysis techniques
  • Advanced biosensing and bioanalysis techniques
  • Dental Implant Techniques and Outcomes
  • Dental Implant Techniques and Outcomes
  • Cellular Mechanics and Interactions
  • Cellular Mechanics and Interactions
  • Dental materials and restorations
  • Dental materials and restorations
  • biodegradable polymer synthesis and properties
  • biodegradable polymer synthesis and properties
  • Silk-based biomaterials and applications
  • Silk-based biomaterials and applications
  • Hydrogels: synthesis, properties, applications
  • Hydrogels: synthesis, properties, applications
  • Mesenchymal stem cell research
  • Mesenchymal stem cell research
  • Graphene and Nanomaterials Applications
  • Graphene and Nanomaterials Applications
  • Periodontal Regeneration and Treatments
  • Periodontal Regeneration and Treatments
  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Educational Robotics and Engineering
  • Educational Robotics and Engineering
  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • Osteoarthritis Treatment and Mechanisms
  • Osteoarthritis Treatment and Mechanisms
  • Advanced Drug Delivery Systems
  • Advanced Drug Delivery Systems

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: